Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ai Takeda-Watanabe"'
Autor:
Munehiro Kitada, Ai Takeda-Watanabe, Atsushi Nakagawa, Keizo Kanasaki, Shin-ichi Tsuda, Daisuke Koya, Makoto Nishizawa, Kazunori Konishi, Mizue Fujii
Publikováno v:
BMJ Open Diabetes Research & Care
Objective The objective of this study is to elucidate the effect of anagliptin on glucose/lipid metabolism and renoprotection in patients with type 2 diabetic nephropathy. Methods Twenty-five patients with type 2 diabetic nephropathy received anaglip
Autor:
Toshiki Otoda, Makoto Nishizawa, Atsushi Nakagawa, Kazunori Konishi, Munehiro Kitada, Shin-ichi Tsuda, Daisuke Koya, Keizo Kanasaki, Megumi Kanasaki, Takako Nagai, Ai Takeda-Watanabe
Publikováno v:
Internal Medicine
An impaired ability to sense and respond to drug-induced hypoglycemia is a common and serious complication in diabetic patients. The hypothalamic-pituitary-adrenal (HPA) axis activity plays a critical role in the counterregulatory response to hypogly
Publikováno v:
Clinical Science (London, England : 1979)
Sirtuins are members of the Sir2 (silent information regulator 2) family, a group of class III deacetylases. Mammals have seven different sirtuins, SIRT1–SIRT7. Among them, SIRT1, SIRT3 and SIRT6 are induced by calorie restriction conditions and ar
Autor:
Ai Takeda-Watanabe, Tomoe Nomura, Atsushi Nakagawa, Yasuto Tomita, Ranji Hayashi, Yasuharu Nakano, Munehiro Kitada, Hisakazu Shiroeda, Shin-ichi Tsuda, Takako Nagai, Takeo Kosaka, Keizo Kanasaki, Nobuhiko Ueda, Megumi Kanasaki, Daisuke Koya, Makoto Nishizawa, Kazunori Konishi, Hiroki Ito, Mizue Fujii
Publikováno v:
Journal of Diabetes Investigation
Dipeptidyl peptidase (DPP)‐4 inhibitors are a new class of antidiabetic drugs that increase incretin hormone levels to enhance blood sugar level‐dependent insulinotropic effects, suppress glucagon action, and reduce bowel motility. These incretin
Autor:
Munehiro Kitada, Keizo Kanasaki, Shin-ichi Tsuda, Ai Takeda-Watanabe, Shinji Kume, Daisuke Koya
Publikováno v:
Biochimica et biophysica acta. 1830(10)
Background Calorie restriction (CR) is accepted as an experimental anti-aging paradigm. Several important signal transduction pathways including AMPK and SIRT1 are implicated in the regulation of physiological processes of CR. However, the mechanisms